nifenazone has been researched along with oligonucleotides in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, J; Darabi, R; Egranov, SD; Farida, A; Han, L; Hawke, DH; Hu, Q; Huang, L; Hung, MC; Kim, JJ; Li, J; Li, Y; Liang, K; Lin, C; Nguyen, TK; Sun, C; Sun, D; Wu, J; Xi, Y; Xing, Z; Yang, L; Zhang, P; Zhang, Y; Zhang, Z; Zhao, Z | 1 |
1 other study(ies) available for nifenazone and oligonucleotides
Article | Year |
---|---|
The lncRNA H19 alleviates muscular dystrophy by stabilizing dystrophin.
Topics: Animals; Antipyrine; Cardiomyopathies; Cell Line; Disease Models, Animal; Dystrophin; Enzyme Inhibitors; Female; Half-Life; Humans; Induced Pluripotent Stem Cells; Male; Mice, Inbred C57BL; Mice, Inbred mdx; Mice, Mutant Strains; Muscle Proteins; Muscle Strength; Muscle, Skeletal; Muscular Dystrophies; Mutation; Myocytes, Cardiac; Niacinamide; Oligonucleotides; Protein Stability; Proteolysis; RNA, Long Noncoding; Tripartite Motif Proteins; Ubiquitin-Protein Ligases; Ubiquitination | 2020 |